The AstraZeneca/Oxford Vaccine has landed in Nigeria about 3.94 doses of the COVID-19 vaccine will be made available to Nigerians.
The AstraZeneca/Oxford Vaccine was shipped through the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO, and manufactured by the Serum Institute of India, arrived from Mumbai to Abuja around 11.30 am.
Bashir Ahmad the personal assistant to President Muhammadu Buhari on News and Media has tweeted that, “Nigeria has just received the first batch of Oxford/AstraZeneca COVID—19 vaccine”.
According to a statement from the UN Resident Coordinator in Nigeria, Edward Kallon, “The UN Country Team in Nigeria reiterates its commitment to support the vaccination campaign in Nigeria and help contain the spread of the virus. The arrival of these vaccines in Abuja today marks a milestone for the COVAX Facility in its unprecedented effort to deliver at least 2 billion doses of COVID-19 vaccines globally by the end of 2021″.
Dr Walter Kazadi Mulombo, WHO Representative in Nigeria, added that, “It is heart-warming to witness this epoch-making event and WHO wishes to congratulate the government of Nigeria for its participation in the global vaccine collaboration (COVAX) efforts and its commitment to protecting Nigerians against this pandemic”.
He revealed that, “Vaccines are a critical new tool in the battle against COVID-19; therefore, this is a step in the right direction. These vaccines have undergone rigorous regulatory processes at global and country level and have been deemed safe and effective”.
Add Comment